RET and non-small cell lung carcinoma: In this regard, Schubert and colleagues established three patient-derived NSCLC cell lines, two harboring KIF5B-RET fusion (CUTO22 and CUTO32) and one containing an EML4-RET rearrangement (CUTO42) [77].